References
- Arjmandi BH, Getlinger MJ, Goyal NV, Alekel L, Hasler CM, Juma S, Drum ML, Hollis BW, Kukreja SC. Role of soy protein with normal or reducedisoflavone content in reversing bone loss induced by ovarian hormone deficiency in rats. Am J Clin Nutr. 1998. 68: 1358S-1363S.
- Aschner PJ. The role for saxagliptin within the management of type 2 diabetes mellitus: an update from the 2010 European Association for the Study of Diabetes (EASD) 46th annual meeting and the American Diabetes Association (ADA) 70th scientific session. Diabetol Metab Syndr. 2010. 15: 2-69.
- Barnes JL, Gorin Y. Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases. Kidney Int. 2011. 79: 944-956. https://doi.org/10.1038/ki.2010.516
- Breuhahn K, Longerche T, Schirmacher P. Dysregulation of growth factor signaling in human hepatocellular carcinoma. Oncogene. 2006. 25: 3787-3800. https://doi.org/10.1038/sj.onc.1209556
- Carmona-Cuenca I, Roncero C, Sancho P, Caja L, Fausto N, Fernandez M, Fabregat I. Upregulation of the NADPH oxidase NOX4 by TGF-beta in hepatocytes is required for its pro-apoptotic activity. J Hepatol. 2008. 49: 965-976. https://doi.org/10.1016/j.jhep.2008.07.021
- Choi SC, Seok SJ. The effect of fat diet on inflammatory markers and blood coagulation system in rats. J Exp Biomed Sci. 2012. 18: 237-243.
- de Mochel NS, Seronello S, Wang SH, Ito C, Zheng JX, Liang TJ, Lambeth JD, Choi J. Hepatocyte NAD(P)H oxidases as an endogenous source of reactive oxygen species during hepatitis C virus infection. Hepatology. 2010. 52: 47-59. https://doi.org/10.1002/hep.23671
- Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev. 1999. 20: 649-688.
- Escher P, Wahli W. Peroxisome proliferator-activated receptors: insight into multiple cellular functions. Mutat Res. 2000. 448: 121-138. https://doi.org/10.1016/S0027-5107(99)00231-6
- Franco DL, Mainez J, Vega S, Sancho P, Murillo MM, de Frutos CA, Del Castillo G, Lopez-Blau C, Fabregat I, Nieto MA. Snail1 suppresses TGF-beta-induced apoptosis and is sufficient to trigger EMT in hepatocytes. J Cell Sci. 2010. 123: 3467-3477. https://doi.org/10.1242/jcs.068692
- Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology. 2006. 43: S99-S112. https://doi.org/10.1002/hep.20973
- Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, Culebras A, DeGraba TJ, Gorelick PB, Guyton JR, Hart RG, Howard G, Kelly-Hayes M, Nixon JV, Sacco RL. American Heart Association; American Stroke Association Stroke Council. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2006. 24: e873-e923.
- Fain JN, Kanu A, Bahouth SW, Cowan GS Jr, Hiler ML, Leffler CW. Comparison of PGE2, prostacyclin and leptin release by human adipocytes versus explants of adipose tissue in primary culture. Prostaglandins Leukot Essent Fatty Acids. 2002. 6: 467-473.
- Finck BN, Lehman JJ, Leone TC, Welch MJ, Bennett MJ, Kovacs A, Han X, Gross RW, Kozak R, Lopaschuk GD, Kelly DP. The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. J Clin Invest. 2002. 109: 121-130. https://doi.org/10.1172/JCI0214080
- Gnacinska M, Maigorzewicz S, Stojek M, Lysiak-Szydlowska W, Sworczak K. Role of adipokines in complicationsrelated to obesity. Adv Med Sci. 2009. 2: 150-157.
- Goldenberg I, Benderly M, Goldbourt U. Update on the use of fibrates: focus on bezafibrate. Vasc Health Risk Manag. 2008. 4: 131-141. https://doi.org/10.2147/vhrm.2008.04.01.131
- Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ. Coordinating Committee of the National Cholesterol Education Program. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol. 2004. 3: 720-732.
- Hassa PO, Hottiger MO. The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases. Front Biosci. 2008. 13: 3046-3082. https://doi.org/10.2741/2909
- Curtin NJ. PARP inhibitors for cancer therapy. Expert Rev Mol Med. 2005. 7: 1-20.
- Ha HC, Snyder SH. Poly (ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc Natl Acad Sci. 1999. 96: 13978-13982. https://doi.org/10.1073/pnas.96.24.13978
- Hecker L, Vittal R, Jones T, Jagirdar R, Luckhardt TR, Horowitz JC, Pennathur S, Artinez FJ, Thannickal VJ. NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat Med. 2009. 5: 1077-1081.
- Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993. 259: 87-91. https://doi.org/10.1126/science.7678183
- Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest. 1995. 5: 2409-2415.
- Ho HM, Leung LK, Chan FL, Huang Y, Chen ZY. Soy leaf lowers the ratio of non-HDL to HDL cholesterol in hamsters. J Agric Food Chem. 2003. 51: 4554-4558. https://doi.org/10.1021/jf021197c
- Jiang JX, Chen X, Serizawa N, Szyndralewiez C, Page P, Schroder K, Brandes RP, Devaraj S, Torok NJ. Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo. Free Radic Biol Med. 2012. 53: 289-296. https://doi.org/10.1016/j.freeradbiomed.2012.05.007
- Kahn HS. The "lipid accumulation product" performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord. 2005. 8: 5-26.
- Masterjohn C, Bruno RS. Therapeutic potential of green tea in nonalcoholic fatty liver disease. Nutr Rev. 2012. 1: 41-56.
- Massague J. TGF-beta in cancer. Cell. 2008. 134: 215-230. https://doi.org/10.1016/j.cell.2008.07.001
- Matsuzaki K. Modulation of TGF-beta signaling during progression of chronic liver diseases. Front Biosci. 2009. 14: 2923-2934.
- Mandard S, Muller M, Kersten S. Peroxisome proliferatoractivated receptor alpha target genes. Cell Mol Life Sci. 2004. 61: 393-416. https://doi.org/10.1007/s00018-003-3216-3
- Niu YH, Yi RT, Liu HL, Chen TY, Zhang SL, Zhao YR. Expression of COX-2 and PPARg in the livers of patients with acute on chronic HBV-related liver failure and their relationship with clinic parameters. Zhonghua Gan Zang Bing ZaZhi. 2011. 7: 511-516.
- Nunez Martinez O, Clemente Ricote G, Garcia Monzon C. Role of cyclooxygenase-2 in the pathogenesis of chronic liver diseases. Med Clin (Barc) 2003. 121: 743-748. https://doi.org/10.1016/S0025-7753(03)74082-2
- Ozaki T, Habara K, Matsui K, Kaibori M, Kwon AH, Ito S, Nishizawa M, Okumura T. Dexamethasone inhibits the induction of iNOS gene expression through destabilization of its mRNA in proinflammatory cytokine-stimulated hepatocytes. Shock. 2010. 33: 64-69. https://doi.org/10.1097/SHK.0b013e3181a7fd74
- Piskunova TS, Yurova MN, Ovsyannikov AI, Semenchenko AV, Zabezhinski MA, Popovich IG, Wang ZQ, Anisimov VN. Deficiency in Poly (ADP-ribose) Polymerase-1 (PARP-1) Accelerates Aging and Spontaneous Carcinogenesis in Mice. Curr Gerontol Geriatr Res. 2008. 7541-7590.
- Piskunova TS, Iurova MN, Zabezhinskii MA, Anisimov VN. Poly (ADP-ribosa) polymerase-the relationships with life span and carcinogenesis. Adv Gerontol. 2007. 20: 82-90.
- Pollard M, Wolter W, Sun L. Prevention of induced prostaterelated cancer by soy protein isolate/isoflavonesupplemented diet in Lobund-Wistar rats. In Vivo. 2000. 14: 389-392.
- Poynter ME, Daynes RA. Peroxisome proliferator-activated receptor alpha activation modulates cellular redox status, represses nuclear factor-kappaB signaling, and reduces inflammatory cytokine production in aging. J Biol Chem. 1998. 273: 32833-32841. https://doi.org/10.1074/jbc.273.49.32833
- Proell V, Carmona-Cuenca I, Murillo MM, Huber H, Fabregat I. TGF-beta dependentregulation of oxygen radicals during transdifferentiation of activated hepaticstellate cells to myofibroblastoid cells. Comp Hepatol. 2007. 6: 1-10. https://doi.org/10.1186/1476-5926-6-1
- Raisz LG. Physiology and pathophysiology of bone remodeling. Clin Chem. 1999. 8: 1353-1368.
- Reinehr R, Becker S, Eberle A, Grether-Beck S, Häussinger D. Involvement of NADPH oxidase isoforms and Src family kinases in CD95-dependent hepatocyte apoptosis. J Biol Chem. 2005. 29: 179-194.
- Rossmanith W, Schulte-Hermann R. Biology of transforming growth factor beta in hepatocarcinogenesis. Microsc Res Tech. 2001. 52: 430-436. https://doi.org/10.1002/1097-0029(20010215)52:4<430::AID-JEMT1028>3.0.CO;2-3
- Roepstorff G, Halberg N, Hillig T, Saha AK, Ruderman NB. Malonyl-CoA and carnitine in regulation of fat oxidation in human skeletal muscle during exercise. Am J Physiol Endoclinol Metab. 2005. 288: E133-E142.
- Sanchez A, Alvarez AM, Benito M, Fabregat I. Apoptosis induced by transforming growth factor-beta in fetal hepatocyte primary cultures: involvement of reactive oxygen intermediates. J Biol Chem. 1996. 271: 7416-7422. https://doi.org/10.1074/jbc.271.13.7416
- Simmons DL, Botting RM, Hla T. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev. 2004. 3: 387-437.
- Sui Y, Zhao HL, Wong VC, Brown N, Li XL, Kwan AK, Hui HL, Ziea ET, Chan JC. A systematic review on use of Chinesemedicine and acupuncture for treatment of obesity. Obes Rev. 2012. 5: 409-430.
- Tilley SL, Coffman TM, Koller BH. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Invest. 2001. 1: 15-23.
- Torres-Rovira L, Astiz S, Caro A, Lopez-Bote C, Ovilo C, Pallares P, Perez-Solana ML, Sanchez-Sanchez R, Gonzalez-Bulnes A. Diet-induced swine model with obesity/leptin resistance for the study of metabolic syndrome and type 2 diabetes. Scientific World Journal. 2012. 21: 101-149.
- Torres DM, Harrison SA. Diagnosis and therapy of nonalcoholicsteatohepatitis. Gastroenterology. 2008. 134: 1682-1698. https://doi.org/10.1053/j.gastro.2008.02.077
- Tordjman K, Standley KN, Bernal-Mizrachi C, Leone TC, Coleman T, Kelly DP, Semenkovich CF. PPARalpha suppresses insulin secretion and induces UCP2 in insulinoma cells. Environ Health Perspect. J Lipid Res. 2002. 6: 936-944.
- Travis WD, Garg K, Franklin WA, Wistuba II, Sabloff B, Noguchi M, Kakinuma R, Zakowski M, Ginsberg M, Padera R, Jacobson F, Johnson BE, Hirsch F, Brambilla E, Flieder DB, Geisinger KR, Thunnissen F, Kerr K, Yankelevitz D, Franks TJ, Galvin JR, Henderson DW, Nicholson AG, Hasleton PS, Roggli V, Tsao MS, Cappuzzo F, Vazquez MJ. VandenBerghe W, Vermeulen L, Delerive P, De Bosscher K, Staels B, Haegeman G. A paradigm for gene regulation: inflammation, NF-kappaB and PPAR. Adv Exp Med Biol. 2003. 544: 181-196. https://doi.org/10.1007/978-1-4419-9072-3_22
-
Wang C, Xu CX, Krager SL, Bottum KM, Liao DF, Tischkau SA. Aryl hydrocarbon receptor deficiency enhances insulin sensitivity and reduces PPAR-
${\alpha}$ pathway activity in mice. Environ Health Perspect. 2011. 12: 1739-1744. - Wilcox JN, Blumenthal BF. Thrombotic mechanisms in atherosclerosis: potential impact of soy proteins. J Nutr. 1995. 125: 631S-638S.
- Wilson TA, Meservey CM, Nicolosi RJ. Soy lecithin reduces plasma lipoprotein cholesterol and early atherogenesis in hypercholesterolemic monkeys and hamsters: beyond linoleate. Atherosclerosis. 1998. 140: 147-153.
- Wu T. Cyclooxygenase-2 and prostaglandin signaling in cholangiocarcinoma. Biophys Acta. 2005. 1755: 135-150.
- Xu H, Uysal KT, Becherer JD, Arner P, Hotamisligil GS. Altered tumor necrosis factor-alpha (TNF-alpha) processing in adipocytes and increased expression of transmembrane TNF-alpha in obesity. Diabetes. 2002. 6: 1876-1883.
- Zang Y, Sato H, Igarashi K. Anti-diabetic effects of a kaempferol glycoside-rich fraction from unripe soybean (Edamame, Glycine max L. Merrill. 'Jindai') leaves on KKA(y) mice. Biosci Biotechnol Biochem. 2011. 75: 1677-1684. https://doi.org/10.1271/bbb.110168
- Zhao HL, Sui Y, Qiao CF, Yip KY, Leung RK, Tsui SK, Lee HM, Wong HK, Zhu X, Siu JJ, He L, Guan J, Liu LZ, Xu HX, Tong PC, Chan JC. Sustained antidiabetic effects of a berberine-containing Chinese herbal medicine through regulation of hepatic gene expression. Diabetes. 2012. 4: 933-943.
- Zaremba T, Thomas HD, Cole M, Coulthard SA, Plummer ER, Curtin NJ. Poly (ADP-ribose) polymerase-1 (PARP-1) pharmacogenetics, activity and expression analysis in cancer patients and healthy volunteers. Biochem. 2011. 436: 671-679. https://doi.org/10.1042/BJ20101723